Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 497,076 | 365,440 | 212,688 | 96,576 | 74,941 |
| Marketable Securities | 338,004 | 204,940 | 342,485 | 480,290 | 498,487 |
| Receivables | 11,858 | 7,914 | 9,382 | 12,676 | 9,257 |
| Inventories | 10,736 | 10,536 | 10,518 | 9,069 | 8,667 |
| TOTAL | $877,358 | $599,521 | $584,646 | $612,690 | $601,356 |
| Non-Current Assets | |||||
| PPE Net | 31,156 | 26,833 | 24,952 | 60,355 | 46,542 |
| Investments And Advances | 16,466 | 57,383 | 100,618 | 105,435 | 135,306 |
| Intangibles | 129,625 | 130,053 | 130,476 | 130,900 | 131,328 |
| Other Non-Current Assets | 40,868 | 41,032 | 34,194 | 2,922 | 2,860 |
| TOTAL | $218,115 | $255,301 | $290,240 | $299,612 | $316,036 |
| Total Assets | $1,095,473 | $854,822 | $874,886 | $912,302 | $917,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,412 | 3,686 | 3,895 | 4,453 | 2,421 |
| Accrued Expenses | 13,259 | 10,808 | 7,981 | 12,495 | 9,363 |
| TOTAL | $100,832 | $93,422 | $77,950 | $78,313 | $73,377 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 36,607 | 23,449 |
| Deferred Revenues | 78,192 | 75,699 | 64,572 | 61,365 | 61,593 |
| Other Non-Current Liabilities | 44,741 | 43,999 | 36,545 | 93 | 44 |
| TOTAL | $219,594 | $231,461 | $245,373 | $262,950 | $258,090 |
| Total Liabilities | $320,426 | $324,883 | $323,323 | $341,263 | $331,467 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 136,772 | 135,794 | 126,888 | 126,318 | 124,339 |
| Common Shares | 13 | 12 | 12 | 12 | 12 |
| Retained earnings | -467,042 | -430,323 | -396,788 | -365,478 | -344,867 |
| Other shareholders' equity | 1,427 | 2,153 | 3,313 | 671 | 572 |
| TOTAL | $775,047 | $529,939 | $551,563 | $571,039 | $585,925 |
| Total Liabilities And Equity | $1,095,473 | $854,822 | $874,886 | $912,302 | $917,392 |